. Author manuscript; available in PMC: 2014 Apr 18.

Published in final edited form as: Gynecol Oncol. 2012 Jun 24;127(1):136–140. doi: 10.1016/j.ygyno.2012.06.027

Table 2.

Concordance index and standard deviation for the training and testing of recurrence-free survival, cause-specific survival, and overall survival for the (A) PET model nomograms and (B) FIGO stage.

	Training	Testing
A. PET-based nomograms
Recurrence-free survival	0.740 ± 0.011	0.741 ± 0.099
Disease-specific survival	0.727 ± 0.015	0.739 ± 0.153
Overall survival	0.675 ± 0.014	0.658 ± 0.105
B. FIGO stage
Recurrence-free survival	0.626 ± 0.009	0.605 ± 0.086
Disease-specific survival	0.647 ± 0.013	0.600 ± 0.132
Overall survival	0.602 ± 0.011	0.559 ± 0.152